A DATA Waiver, also known as a MAT Waiver or X-waiver, is a federal authorization that allows qualified healthcare providers to prescribe buprenorphine for opioid use disorder (OUD) outside of traditional opioid treatment programs.
What is a data waiver provider?
A data waiver provider is any clinician—such as a physician, nurse practitioner, or physician assistant—who has completed the required training and registered with the DEA and SAMHSA to prescribe buprenorphine for OUD
These providers get a unique DEA registration number starting with “X” (like X1234567) to include on prescriptions. Once approved, they must report any changes to their practice address or status to both SAMHSA and the DEA within 30 days. SAMHSA hosts a searchable database where patients can confirm a provider’s waiver status.
How do I get buprenorphine waiver?
To get a buprenorphine waiver, physicians must apply to the DEA and complete an 8-hour training course if they plan to treat up to 30 patients; for more than 30 patients, the training requirement jumps to 24 hours
It’s a two-step process: finish the required training (through PCSS or other accredited programs), then file a Notice of Intent (NOI) with SAMHSA. After receiving the waiver, clinicians request a modified DEA registration that includes the “X” number. Since 2023, the “X-waiver” became optional for some providers thanks to policy changes, but it’s still required when prescribing to more than 30 patients in most cases.
How do I get a mat waiver?
To obtain a MAT waiver, clinicians must complete 24 hours of specialized education in addiction medicine and register with SAMHSA and the DEA
The training covers safe prescribing, patient assessment, and regulatory requirements. For nurse practitioners and physician assistants, this usually means completing an approved 24-hour course (like PCSS-MAT), then submitting an NOI to SAMHSA. Once approved, providers can prescribe buprenorphine right away—up to 30 patients at first. Costs vary by program but generally run between $150 and $300. After the first year, providers can apply to increase their patient limit to 100 or 275 by completing extra steps.
Do you need a waiver to prescribe buprenorphine?
Most providers need a waiver to prescribe buprenorphine for opioid use disorder, except in limited cases like pain management or as part of an opioid treatment program
The federal rule applies to physicians, NPs, and PAs prescribing buprenorphine mainly for OUD. Since 2023, the X-waiver isn’t required for clinicians treating up to 30 patients for OUD under federal law. Providers still need to follow state rules, which can be stricter. Always double-check your state’s guidelines—some add extra certification or oversight.
Do you need a waiver to prescribe naltrexone?
No waiver is needed to prescribe naltrexone—any licensed healthcare provider with prescribing authority can order it for OUD or alcohol use disorder
Naltrexone (brand names: Vivitrol, ReVia) is classified as an opioid antagonist and isn’t a controlled substance. That makes it easier to access for both patients and providers. It can be prescribed as a daily pill or a monthly injection. Unlike buprenorphine, there are no federal training or registration requirements, though state laws may still apply.
What is a Data 2000 waiver ID?
A Data 2000 waiver ID is a unique DEA registration number that starts with the letter “X,” showing a provider is authorized to prescribe buprenorphine for OUD
This ID replaces the standard DEA number on buprenorphine prescriptions for addiction treatment. It proves compliance with federal training and authorization rules. Patients can verify a provider’s waiver status using SAMHSA’s treatment locator tool. Providers must renew their DEA registration every 3 years, which also renews their waiver status.
Is buprenorphine used to treat pain?
Yes, buprenorphine is FDA-approved to treat moderate to severe chronic pain in patients who need around-the-clock opioid therapy and can’t be managed with non-opioid medications
Brand names like Belbuca (transmucosal film) and Butrans (transdermal patch) are specifically approved for pain. But when used for pain, buprenorphine is prescribed differently than for OUD—different doses and frequencies. Providers must clearly document the reason (pain vs. addiction) to ensure proper insurance coverage and regulatory compliance.
Can any doctor prescribe buprenorphine?
Since 2023, federal law allows most healthcare providers with a standard DEA registration—including doctors, NPs, and PAs—to prescribe buprenorphine for OUD without an X-waiver, up to a patient limit of 30
Physicians, NPs, and PAs can prescribe buprenorphine immediately for up to 30 patients without extra training or a waiver, thanks to the 2023 Consolidated Appropriations Act. But to treat more than 30 patients, providers still need 24 hours of MAT training and must submit an NOI to SAMHSA. Some states add their own requirements, so always check local rules before prescribing.
How much does mat training cost?
MAT waiver training typically costs between $150 and $300 per clinician, depending on the provider and format
Many programs—like those from PCSS-MAT, SAMHSA, and medical associations—charge around $200 on average. Some professional groups offer discounts (like $150) to members. Training is available online, self-paced, or in-person, and usually takes 8 to 24 hours. Continuing education credits (CE/CME) are typically included.
Can nurse practitioners prescribe buprenorphine for pain?
Yes, nurse practitioners with appropriate state licensure and DEA registration can prescribe buprenorphine for pain management without a DATA Waiver
NPs can prescribe buprenorphine (like Belbuca or Butrans) for pain as long as it’s within their scope of practice under state law. A waiver is only needed when prescribing buprenorphine specifically for opioid use disorder. Also, NPs must follow state rules for controlled substance prescribing, which may include registering with a state prescription drug monitoring program (PDMP).
Is Naltrexone the same as Suboxone?
No—naltrexone (Vivitrol) and Suboxone are different medications used for different purposes in addiction treatment
Naltrexone is an opioid antagonist that blocks opioid receptors and is used to prevent relapse in OUD or reduce alcohol cravings. It comes as a daily pill (ReVia) or monthly injection (Vivitrol). Suboxone, however, combines buprenorphine and naloxone as a partial opioid agonist to reduce withdrawal and cravings. Suboxone is taken as a film or tablet under the tongue. They’re both effective but work in totally different ways and at different recovery stages.
Does naltrexone make you feel good?
No—naltrexone does not produce euphoria or a “high”; in fact, it blocks the effects of opioids and alcohol by occupying the brain’s opioid receptors
That’s exactly why it’s used in addiction treatment—to prevent relapse by removing the pleasurable effects of opioids or alcohol. Some patients report side effects like nausea, headache, or fatigue, especially when they first start the medication. Because it completely blocks opioid receptors, patients must be opioid-free for 7–14 days before starting naltrexone to avoid precipitated withdrawal.
Is naloxone the same as naltrexone?
No—naloxone and naltrexone are different medications: naloxone is used to reverse opioid overdoses, while naltrexone is used to prevent relapse in OUD and alcohol use disorder
Naloxone (brand name: Narcan) is a fast-acting opioid antagonist used in emergency overdose situations—it reverses respiratory depression within minutes. Naltrexone, on the other hand, is taken regularly (daily or monthly) to block cravings and prevent relapse. Both block opioid receptors but in totally different contexts and dosages.
What is the data 2000 law?
DATA 2000 is a federal law that allows qualified physicians to prescribe and dispense FDA-approved narcotic medications, including buprenorphine, for the treatment of opioid use disorder outside of licensed opioid treatment programs
Passed as part of the Children’s Health Act of 2000, DATA 2000 created the “X-waiver” system to expand access to addiction treatment. It also set the rules for provider training and registration with SAMHSA. The law expanded in 2016 to include NPs and PAs, and was further updated in 2023 to reduce barriers for small-volume prescribers.
Why would a doctor prescribe buprenorphine?
Doctors prescribe buprenorphine primarily to help patients reduce or stop opioid use, manage withdrawal symptoms, and maintain recovery from opioid use disorder
It works by binding to opioid receptors with less intensity than full opioids, reducing cravings and withdrawal without producing a strong high. Some patients also use buprenorphine off-label to self-manage illicit opioid withdrawal or as a harm-reduction tool. In pain management, buprenorphine is used when other opioids are ineffective or carry higher risk. Its versatility in both addiction and pain care makes it a key tool in modern medicine.
